Product categoriesPersonal Care (Ingested)

Products 1 to 5 of 5

ActoBiotics: AG017 (Celiac Disease) by Actobio Therapeutics
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (5 years ago)
Date last modified: 2019/09/16 16:28 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Personal Care (Ingested)
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:52 (5 years ago)
Known funding amount: 1,900,000 USD
Funding types: Venture Capital
Industry: Health
Market status: On the market
Organization type(s): Private Company
Product categories: Personal Care (Ingested)
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Plaque Attack by Alma College
Biotech components: Probiotic
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:57 (4 years ago)
Date last modified: 2020/02/10 09:57 (4 years ago)
Known funding amount: N/A
Funding types: Foundation + University
Industry: Health
Market status: More information needed
Organization type(s): University
Product categories: Personal Care (Ingested)
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Resveratrol by Evolva
Biotech components: Microbe
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Food + Personal Care (Topical) + Personal Care (Ingested)
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Vitamin D2 by Nucelis
Biotech components: Plant
Business models: B2B + B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Health
Market status: On the market
Organization type(s): Private Company
Product categories: Personal Care (Ingested) + Food
Production process: Open Release
Source: N/A
Trading symbol: N/A
Value chain stage: Finished Product